X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (99) 99
index medicus (56) 56
male (46) 46
female (43) 43
antiviral agents - therapeutic use (34) 34
middle aged (33) 33
pharmacology & pharmacy (28) 28
adult (27) 27
infectious diseases (21) 21
hcv (20) 20
hepatitis c - drug therapy (20) 20
sustained virological response (20) 20
hepatitis c, chronic - drug therapy (19) 19
antiviral agents - adverse effects (18) 18
gastroenterology & hepatology (18) 18
prevalence (18) 18
cirrhosis (17) 17
risk factors (17) 17
hepatitis (15) 15
hepatitis c virus (15) 15
infections (15) 15
ribavirin (15) 15
treatment outcome (15) 15
aged (14) 14
chronic viral-hepatitis (14) 14
drug therapy, combination (14) 14
hepatitis c (14) 14
medicine, research & experimental (13) 13
antiviral agents - pharmacology (12) 12
immunology (12) 12
italy - epidemiology (12) 12
sofosbuvir (12) 12
animals (11) 11
antiviral agents - administration & dosage (11) 11
resistance (11) 11
risk (11) 11
infection (10) 10
liver cirrhosis (10) 10
therapy (10) 10
association (9) 9
child (9) 9
epidemiology (9) 9
genotype (9) 9
hcv infection (9) 9
hepacivirus - genetics (9) 9
microbiology (9) 9
protease inhibitor (9) 9
risk-factors (9) 9
virus-infection (9) 9
case-control studies (8) 8
clinical trials as topic (8) 8
diagnosis (8) 8
hepacivirus - drug effects (8) 8
hepatitis c, chronic - virology (8) 8
igg avidity index (8) 8
prospective studies (8) 8
research (8) 8
virology (8) 8
viruses (8) 8
antiviral agents (7) 7
antiviral therapy (7) 7
cell biology (7) 7
child, preschool (7) 7
genotype 1 infection (7) 7
health aspects (7) 7
hepatitis c - immunology (7) 7
hepatitis c, chronic - blood (7) 7
hepatitis c, chronic - complications (7) 7
interferon-free (7) 7
italy (7) 7
patients (7) 7
pegylated-interferon (7) 7
prevention (7) 7
research article (7) 7
review (7) 7
screening (7) 7
adolescent (6) 6
disease (6) 6
drug therapy (6) 6
fibrosis (6) 6
hepacivirus (6) 6
hepatitis-c virus (6) 6
hepatology (6) 6
interferon (6) 6
interferon-alpha - therapeutic use (6) 6
liver (6) 6
retrospective studies (6) 6
treatment-naive patients (6) 6
virus (6) 6
anti-bacterial agents - therapeutic use (5) 5
antibodies (5) 5
antibodies, viral - blood (5) 5
biochemistry & molecular biology (5) 5
chronic hepatitis-c (5) 5
coinfection (5) 5
controlled-trial (5) 5
drug resistance, viral (5) 5
expression (5) 5
genotypes (5) 5
hepatitis b (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (2) 2
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - Rare Book (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Women's Health, ISSN 1179-1411, 06/2014, Volume 6, Issue 1, pp. 605 - 611
Journal Article
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 07/2014, Volume 12, Issue 7, pp. 763 - 773
About 2% of the world's population is estimated to be chronically infected with hepatitis C virus (HCV). These chronic carriers are at risk of developing liver... 
interferon-free | ledipasvir | sofosbuvir | MK-8742 | ombitasvir | MK-5172 | ABT-450 | asunaprevir | dasabuvir | daclatasvir | Daclatasvir | Ombitasvir | Interferon-free | Ledipasvir | Asunaprevir | Sofosbuvir | Dasabuvir | CONTROLLED-TRIAL | PLUS RIBAVIRIN | LIVER-TRANSPLANTATION | HCV INFECTION | SUSTAINED VIROLOGICAL RESPONSE | PROTEASE INHIBITOR | TREATMENT OPTIONS | GENOTYPE 1 INFECTION | PHARMACOLOGY & PHARMACY | CHRONIC VIRAL-HEPATITIS | DISEASE PROGRESSION | Uridine Monophosphate - administration & dosage | Quinoxalines - adverse effects | Anilides - therapeutic use | Isoquinolines - adverse effects | Hepatitis C - drug therapy | Anilides - adverse effects | Humans | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Carbamates - administration & dosage | Uracil - administration & dosage | Ribavirin - administration & dosage | Uridine Monophosphate - adverse effects | Imidazoles - therapeutic use | Hepatitis C - prevention & control | Quinoxalines - therapeutic use | Uridine Monophosphate - therapeutic use | Disease Eradication | Benzofurans - therapeutic use | Quinoxalines - administration & dosage | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Ribavirin - therapeutic use | Uracil - therapeutic use | Clinical Trials as Topic | Macrocyclic Compounds - adverse effects | Antiviral Agents - administration & dosage | Benzofurans - adverse effects | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Anilides - administration & dosage | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Isoquinolines - therapeutic use | Sulfonamides - adverse effects | Carbamates - adverse effects | Macrocyclic Compounds - administration & dosage | Carbamates - therapeutic use | Hepacivirus | Isoquinolines - administration & dosage | Drug Combinations | Sulfonamides - administration & dosage | Uracil - analogs & derivatives
Journal Article
Reviews on Recent Clinical Trials, ISSN 1574-8871, 01/2014, Volume 9, Issue 2, pp. 115 - 123
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 05/2019, Volume 28, Issue 5, pp. 395 - 397
Pangenotypic drugs against HCV infections led to high rates of virologic response with very limited adverse events. Moreover, they are easy to administer among... 
PHARMACOLOGY & PHARMACY | SOFOSBUVIR | EPIDEMIOLOGY
Journal Article
Journal Article
Journal Article
Journal Article
Expert Review of Anti-Infective Therapy, ISSN 1478-7210, 08/2010, Volume 8, Issue 8, pp. 867 - 870
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, p. e0185728
Journal Article